Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1978 Cerm
2. 1978-cerm
3. 1978cerm
4. Bedapin
5. Bepadin
6. Bepridil
7. Bepridil Monohydrochloride
8. Bepridil Monohydrochloride, Alpha Isomer
9. Bepridil Monohydrochloride, Alpha-isomer
10. Bepridil Monohydrochloride, Monohydrate
11. Bepridil, (+)-isomer
12. Bepridil, (+-)-isomer
13. Bepridil, (-)-isomer
14. Bepridil, Alpha Isomer
15. Bepridil, Alpha-isomer
16. Cerm 1978
17. Cerm-1978
18. Cerm1978
19. Cordium
20. Monohydrochloride, Alpha-isomer Bepridil
21. Monohydrochloride, Bepridil
22. Unicordium
23. Vascor
1. 68099-86-5
2. Bepridil Hcl
3. Cerm 1978
4. 1-isobutoxy-2-pyrrolidino-3-(n-benzylanilino)propane Hydrochloride
5. 2tn7ff3w4m
6. Mls000028456
7. Bepridil Hydrochloride Anhydrous
8. Bepridil (hydrochloride Hydrate)
9. Smr000058419
10. N-benzyl-n-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]aniline;hydrochloride
11. 1-pyrrolidineethanamine,b-[(2-methylpropoxy)methyl]-n-phenyl-n-(phenylmethyl)-,monohydrochloride
12. N-benzyl-n-(3-isobutoxy-2-(pyrrolidin-1-yl)propyl)aniline Hydrochloride
13. Chebi:52712
14. (+/-)-bepridil Hydrochloride Hydrate;org 5730 Hydrochloride Hydrate; Dl-bepridil Hydrochloride Hydrate
15. 1978cerm
16. Sr-01000075304
17. Einecs 268-472-2
18. Unii-2tn7ff3w4m
19. Bepridilhcl
20. Prestwick_697
21. Opera_id_594
22. 1-pyrrolidineethanamine, Beta-((2-methylpropoxy)methyl)-n-phenyl-n-(phenylmethyl)-, Monohydrochloride
23. Mls001076139
24. Mls001333221
25. Mls001333222
26. Mls002222245
27. Bepridil Hydrochloride, Powder
28. Spectrum1503106
29. Regid_for_cid_50088
30. Chembl1257078
31. Dtxsid00964274
32. Hms1569i17
33. Hms1922e17
34. Pharmakon1600-01503106
35. Bcp34263
36. Ex-a3081
37. Tox21_500222
38. Nsc758390
39. Akos024457981
40. N-benzyl-n-(3-isobutoxy-2-pyrrolidin-1-yl-propyl)aniline Hydrochloride
41. Ccg-213110
42. Lp00222
43. N-benzyl-beta-((2-methylpropoxy)methyl)-n-phenylpyrrolidine-1-ethylamine Monohydrochloride
44. Ncgc00093691-01
45. Ncgc00093691-02
46. Ncgc00093691-03
47. Ncgc00093691-04
48. Ncgc00093691-05
49. Ncgc00260907-01
50. Ac-36317
51. Bs-17336
52. Db-055107
53. Hy-103315
54. Cs-0027604
55. Eu-0100222
56. Ft-0641159
57. B 5016
58. D70189
59. 099b865
60. 764b402
61. Org 5730 Hydrochloride Hydrate;bepridil Hcl H2o
62. Sr-01000075304-1
63. Sr-01000075304-7
64. Q27123566
65. 1-(2-(n-benzylanilino)-1-(isobutoxymethyl)ethyl)-pyrrolidine Monohydrochloride
66. 1-pyrrolidineethanamine, .beta.-[(2-methylpropoxy)methyl]-n-phenyl-n-(phenylmethyl)-, Hydrochloride, Hydrate (1:1:1)
Molecular Weight | 403.0 g/mol |
---|---|
Molecular Formula | C24H35ClN2O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 10 |
Exact Mass | 402.2437914 g/mol |
Monoisotopic Mass | 402.2437914 g/mol |
Topological Polar Surface Area | 15.7 Ų |
Heavy Atom Count | 28 |
Formal Charge | 0 |
Complexity | 382 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Arrhythmia Agents
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?